|
AnzemetDrug - Anzemet The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Dolasetron Mesylate Monohydrate
Strength -
EQ 100MG BASE/5ML
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
020624
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 11, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Aventis Pharmaceuticals Inc
Anzemet
Tikosyn 0.25mg Capsule; Oral
Tikosyn 0.5mg Capsule; Oral Anzemet Eq 100mg Base/5ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 200mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 400mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 50mg Base/100ml Injectable; Injection Dobutrex Eq 12.5mg Base/ml Injectable; Injection Taxotere Eq 40mg Base/ml Injectable; Injection Abreva 10% Cream; Topical Tikosyn 0.125mg Capsule; Oral NewDrugInformation |